JNJ has been in the news 429% more than usual
Jan 06, 2026, 7:31 PM
6.23%
What does JNJ do
Johnson & Johnson, headquartered in New Brunswick, New Jersey, employs 131,900 people and focuses on healthcare through its Innovative Medicine and MedTech segments. Innovative Medicine targets various therapeutic areas, while MedTech offers products for orthopedic and cardiovascular interventions.
JNJ has been in the news recently: The FDA has lifted the clinical hold on GH Research Plc's IND for GH001, while Johnson & Johnson is facing growing legal challenges, including nearly $1 billion in trial losses and a recent $40 million verdict related to talc products. Additionally, Johnson & Johnson reported topline results from the Phase 2b JASMINE study of nipocalimab for lupus patients.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.